Shin Poong Pharm.Co.Ltd. (019170) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shin Poong Pharm.Co.Ltd. (019170) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.42 Billion ≈ $2.31 Million USD) by net assets (₩270.73 Billion ≈ $183.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shin Poong Pharm.Co.Ltd. stock valuation for the company's overall valuation and market capitalisation.
Shin Poong Pharm.Co.Ltd. - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Shin Poong Pharm.Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shin Poong Pharm.Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shin Poong Pharm.Co.Ltd. ranked by their cash flow conversion efficiency. Explore 019170 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Groenlandsbanken AS
CO:GRLA
|
0.003x |
|
Zhejiang Tuna Environmental Science & Technology Co Ltd
SHG:603177
|
0.063x |
|
Shanghai DOBE Cultural & Creative Industry Development (Group) Co. LTD.
SHE:300947
|
N/A |
|
Richtech Robotics Inc. Class B Common Stock
NASDAQ:RR
|
0.004x |
|
All For One Steeb AG
F:A1OS
|
0.059x |
|
Sappe Public Company Limited
BK:SAPPE
|
0.070x |
|
Cosmos Group Co Ltd
SHE:002133
|
0.042x |
|
Xpro India Limited
NSE:XPROINDIA
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Shin Poong Pharm.Co.Ltd. (2004–2025)
The table below shows the annual cash flow conversion efficiency of Shin Poong Pharm.Co.Ltd. from 2004 to 2025. View 019170 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩270.73 Billion ≈ $183.47 Million |
₩17.25 Billion ≈ $11.69 Million |
0.064x | +208.54% |
| 2024-12-31 | ₩258.09 Billion ≈ $174.90 Million |
₩-15.15 Billion ≈ $-10.27 Million |
-0.059x | +35.91% |
| 2023-12-31 | ₩270.78 Billion ≈ $183.51 Million |
₩-24.81 Billion ≈ $-16.81 Million |
-0.092x | -14.59% |
| 2022-12-31 | ₩330.76 Billion ≈ $224.15 Million |
₩-26.44 Billion ≈ $-17.92 Million |
-0.080x | +60.09% |
| 2021-12-31 | ₩354.56 Billion ≈ $240.28 Million |
₩-71.03 Billion ≈ $-48.13 Million |
-0.200x | -473.78% |
| 2020-12-31 | ₩374.33 Billion ≈ $253.68 Million |
₩20.06 Billion ≈ $13.60 Million |
0.054x | -42.08% |
| 2019-12-31 | ₩209.13 Billion ≈ $141.72 Million |
₩19.35 Billion ≈ $13.11 Million |
0.093x | -40.11% |
| 2018-12-31 | ₩207.48 Billion ≈ $140.61 Million |
₩32.05 Billion ≈ $21.72 Million |
0.154x | +219.87% |
| 2017-12-31 | ₩210.11 Billion ≈ $142.39 Million |
₩10.15 Billion ≈ $6.88 Million |
0.048x | -44.76% |
| 2016-12-31 | ₩216.85 Billion ≈ $146.96 Million |
₩18.96 Billion ≈ $12.85 Million |
0.087x | +72.25% |
| 2015-12-31 | ₩194.86 Billion ≈ $132.05 Million |
₩9.89 Billion ≈ $6.70 Million |
0.051x | +20285.40% |
| 2014-12-31 | ₩191.51 Billion ≈ $129.79 Million |
₩-48.16 Million ≈ $-32.64K |
0.000x | -100.42% |
| 2013-12-31 | ₩190.79 Billion ≈ $129.29 Million |
₩11.45 Billion ≈ $7.76 Million |
0.060x | -63.21% |
| 2012-12-31 | ₩188.73 Billion ≈ $127.90 Million |
₩30.79 Billion ≈ $20.87 Million |
0.163x | +2.16% |
| 2011-12-31 | ₩179.86 Billion ≈ $121.89 Million |
₩28.73 Billion ≈ $19.47 Million |
0.160x | +111.50% |
| 2010-12-31 | ₩150.39 Billion ≈ $101.92 Million |
₩11.36 Billion ≈ $7.70 Million |
0.076x | +11.76% |
| 2009-12-31 | ₩145.31 Billion ≈ $98.48 Million |
₩9.82 Billion ≈ $6.65 Million |
0.068x | -63.33% |
| 2008-12-31 | ₩127.93 Billion ≈ $86.70 Million |
₩23.57 Billion ≈ $15.97 Million |
0.184x | +114.71% |
| 2007-12-31 | ₩113.81 Billion ≈ $77.12 Million |
₩9.77 Billion ≈ $6.62 Million |
0.086x | -14.81% |
| 2006-12-31 | ₩106.28 Billion ≈ $72.02 Million |
₩10.71 Billion ≈ $7.25 Million |
0.101x | +99.59% |
| 2005-12-31 | ₩97.65 Billion ≈ $66.18 Million |
₩4.93 Billion ≈ $3.34 Million |
0.050x | -57.97% |
| 2004-12-31 | ₩87.36 Billion ≈ $59.20 Million |
₩10.49 Billion ≈ $7.11 Million |
0.120x | -- |
About Shin Poong Pharm.Co.Ltd.
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial dru… Read more